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Summary
Proper regulation of cell morphogenesis and migra-
tion by adhesion and growth-factor receptors requires
Abl-family tyrosine kinases [1–3]. Several substrates
of Abl-family kinase have been identified, but they
are unlikely to mediate all of the downstream actions
of these kinases on cytoskeletal structure. We used
a human protein microarray to identify the actin-regu-
latory protein cortactin as a novel substrate of the Abl
and Abl-related gene (Arg) nonreceptor tyrosine ki-
nases. Cortactin stimulates cell motility [4–6], and its
upregulation in several cancers correlates with poor
prognosis [7]. Even though cortactin can be tyrosine
phosphorylated by Src-family kinases in vitro [8], we
show that Abl and Arg are more adept at binding and
phosphorylating cortactin. Importantly, we demon-
strate that platelet-derived growth-factor (PDGF)-
induced cortactin phosphorylation on three tyrosine
residues requires Abl or Arg. Cortactin triggers F-
actin-dependent dorsal waves in fibroblasts after
PDGF treatment and thus results in actin reorganiza-
tion and lamellipodial protrusion [9]. We provide
evidence that Abl/Arg-mediated phosphorylation of
cortactin is required for this PDGF-induced dorsal-
wave response. Our results reveal that Abl-family
kinases target cortactin as an effector of cytoskeletal
rearrangements in response to PDGF.
Results and Discussion
Adhesion and growth-factor receptors act through Abl-
family tyrosine kinases to regulate cell morphogenesis
and migration. Genetic studies demonstrate that Abl-
family kinases are essential for epithelial-cell morpho-
genesis [10, 11], cell migration and chemotaxis [12–
14], axon pathfinding [15], and dendrite maintenance
[16]. Abl-family-kinase signaling pathways also become
disrupted in cancer cells [17]. The Bcr-Abl oncoprotein,
resulting from a reciprocal chromosomal translocation
involving the bcr and abl genes, causes chronic
*Correspondence: anthony.koleske@yale.edumyelogenous and acute lymphocytic leukemia in hu-
mans [18]. Cells transformed with Bcr-Abl exhibit altered
migratory [19] and adhesive behavior [20] and exhibit
reduced responsiveness to chemotactic cues [21].
We used a human protein microarray to search for
novel Abl/Arg substrates. The microarray contained
2400 different human proteins spotted in duplicate (the
accession numbers of the microarrayed proteins are
listed in Table S1 in the Supplemental Data available
with this article online). The array also contained control
proteins—protein kinases A and C and the Abl/Arg sub-
strate Crk [22]—spotted at regular intervals. Incubating
the array with g-33P-ATP alone led to autophosphoryla-
tion of protein kinases A and C, generating landmark sig-
nals for subsequent alignment and analysis of the array.
Incubating the array with g-33P-ATP + Arg labeled Crk
as well as other novel substrates (Figure 1A). These
Arg-dependent phosphorylation events were inhibited
by the Abl/Arg kinase inhibitor STI-571 [23] and were
eliminated by treatment of the array with a tyrosine
phosphatase (Figure S1 and data not shown), indicating
that these signals arose from Arg-mediated tyrosine
phosphorylation of the proteins. We focused on one
newly identified putative substrate, cortactin, because
it is a known regulator of cytoskeletal rearrangements
and was a kinetically favorable Abl and Arg substrate
in solution-based assays (see below).
Because Abl and Arg are related in sequence and
function, we tested whether both kinases could bind
cortactin. A protein microarray containing Abl, Arg,
and bovine serum albumin (BSA) was probed with a
glutathione-S-transferase (GST)-cortactin fusion protein
and detection with GST antibodies followed. In a pilot
experiment, cortactin bound to both Abl and Arg but
not to BSA (Figure S1B). This interaction was also de-
tected when cortactin was spotted onto microarrays
and probed with Abl or Arg (Figure S1B). No signal
was detected upon probing with the unrelated Chk1
and c-Kit kinases (Figure S1B). To determine whether
other protein kinases interact with cortactin, we pre-
pared a protein microarray containing 96 human protein
kinases and probed it with purified cortactin. The stron-
gest signals for cortactin interactions were observed
with Abl, Arg, and the serine-threonine kinase Pak3
(Figure 1B). The Pak3-homolog Pak1 has been shown
to bind to cortactin in vitro [24]. Notably, cortactin prob-
ing of Src-family kinases (FynT, Lck, Src, Yes, Hck, and
LynA) yielded weaker signals than Abl, Arg, and Pak3.
In vitro protein-kinase assays demonstrated that Abl
and Arg phosphorylate cortactin in solution with KM (Mi-
chaelis constant) values (Abl KM = 23 nM, Arg KM = 80
nM) that are lesser than those of previously reported
physiological Abl/Arg substrates (Arg KM for p190Rho-
GAP = 120 nM, Abl/Arg KM for Crk = 500 nM) (Figure 1C)
[25, 26]. Treatment with PDGF is known for inducing Abl
and Arg kinase activities [27, 28] and increasing tyrosine
phosphorylation on cortactin [29] in fibroblasts. PDGF
treatment stimulates cortactin phosphorylation 5-fold
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446Figure 1. Abl/Arg Phosphorylate and Bind to Cortactin In Vitro
(A) Kinase assays on protein microarrays. Twenty four hundred human proteins were expressed in insect cells as GST-fusions, purified, and ar-
rayed in duplicate on glass slides. Duplicate microarrays were incubated with g-33P-ATP alone or Arg kinase and g-33P-ATP. Protein kinases A/C
and Crk served as autophosphorylation and Arg-substrate controls and as landmarks for aligning and analyzing data. Putative Arg substrates are
indicated.
(B) GST-cortactin binds preferentially to Abl, Arg, and Pak3. A microarray containing 96 kinases was probed with cortactin. GST-cortactin binds
strongly to Pak3, Abl, and Arg (indicated by thick arrowheads) but more weakly to Src-family kinases (indicated by thin arrowheads). Plot shows
mean 6 SD for each of two spots of each kinase.
(C) Phosphorylation of cortactin by Abl, Arg, and Src in vitro. Increasing concentrations of purified full-length recombinant His6-cortactin were
incubated with Abl, Arg, or Src in the presence of g-32P-ATP. Phosphorimage of representative kinase reactions is shown on the left.
Concentration dependence of cortactin phosphorylation is shown on the right. KM values for each kinase are indicated.in wild-type mouse 3T3 fibroblasts (WT cells) (Figures 2A
and 2B). PDGF-induced cortactin phosphorylation was
significantly reduced in arg–/– cells and nearly absent
in abl–/– cells, whereas the loss of both kinases in
abl–/–arg–/– cells completely eliminates cortactin phos-
phorylation (Figures 2A and 2B). Re-expression of Abl-
YFP in abl–/– cells or Arg-YFP in arg–/– cells rescues
PDGF-dependent cortactin phosphorylation (Figures
S2A and S2B).Cortactin phosphorylation is increased in cells with
elevated Src activity [30], and PDGF-induced cortactin
phosphorylation is reduced by inhibiting Src [31], sug-
gesting that cortactin is phosphorylated by Src or other
kinases downstream of Src. Indeed, coexpression of Src
with cortactin in HEK293 cells led to increased cortactin
phosphorylation (Figure S3A). Src phosphorylates cor-
tactin directly in vitro, albeit with a KM value (320 nM)
that is 14- and 4-fold greater than those for Abl and
PDGF Induces Abl/Arg to Phosphorylate Cortactin
447Figure 2. PDGF-Dependent Cortactin Phosphorylation Requires Abl, Arg, and Src-Family Kinases
(A) Abl-family and Src-family kinases are required for PDGF-induced phosphorylation of endogenous cortactin. WT (lanes 1–4), abl–/– (lanes 5–8),
arg–/– (lanes 9–12), abl–/–arg–/– (lanes 13–16), and src–/–yes–/–fyn–/– (SYF) (lanes 17–20) mouse 3T3 cells were stimulated with 5 ng/ml PDGF for 0, 2,
5, or 10 min. Cortactin was immunoprecipitated and immunoblotted with antibodies against phosphotyrosine (PY) or cortactin.
(B) Quantitation of PDGF-induced cortactin phosphorylation. Phosphotyrosine content was normalized for the amount of cortactin immunopre-
cipitated at each time point. The fold increase is the ratio of this normalized phosphotyrosine content at the 2, 5, and 10 min time points to
the zero time point. Mean 6 SEM. WT, n = 11 experiments; abl–/–, n = 4 experiments; arg–/–, n = 4 experiments; abl–/–arg–/–, n = 6 experiments;
SYF, n = 10 experiments. ANOVA between data for all genotypic classes, p < 0.0001. Post-hoc Fisher’s PLSD test for WT at 0 min versus 5 or
10 min time point: *p < 0.0001.Arg, respectively (Figure 1C). PDGF-dependent cortac-
tin phosphorylation was abrogated in src–/–yes–/–fyn–/–
(SYF) cells (Figure 2A). Re-expression of Src in SYF cells
(SYF + Src cells) leads to constitutive cortactin phos-
phorylation, which is not further increased upon PDGF
treatment (Figures S2A and S2B). This constitutive
phosphorylation may result from the high levels of Src
expression in SYF + Src cells (R10-fold greater than
normal endogenous levels).
The kinase activities of Src- and Abl-family kinases
are both activated by PDGF treatment, and PDGF-
dependent activation of Abl and Arg kinase activities re-
quires Src [27, 28]. There are therefore three possibilities
that explain how Src- and Abl-family kinases interact to
achieve cortactin phosphorylation: (1) Src phosphory-
lates cortactin directly, (2) Src, Abl, and Arg each inde-
pendently phosphorylate cortactin, or (3) Src activates
Abl/Arg to phosphorylate cortactin. The finding that
PDGF-stimulated cortactin phosphorylation is absent
in abl–/–arg–/– cells (Figure 2A, lanes 13–16) eliminates
possibility 1. Moreover, the finding (in Figure 2) that
Src-family kinases and Abl-family kinases are both
required for cortactin phosphorylation eliminatespossibility 2. Together with previous work [27, 28], our
data is most consistent with Src acting as an intermedi-
ary that activates Abl and Arg to phosphorylate cortactin
after PDGF stimulation. Thus, although Src can phos-
phorylate cortactin in vitro (Figure 1C), the cumulative
data suggest that it plays an indirect role in PDGF-
induced cortactin phosphorylation.
Cortactin can be phosphorylated on tyrosines 421,
466, and 482 in vitro [4]. Mutation of each tyrosine indi-
vidually reduced phosphotyrosine content relative to
WT cortactin (Figure S3B). Mutation of Y421, Y466,
and Y482 to phenylalanine (cortactin-3F) completely ab-
rogated cortactin phosphorylation in vitro and in vivo
upon coexpression with Abl or Arg (Figures S3B and
S3C). These observations indicate that cortactin resi-
dues Y421, Y466, and Y482 are required for its phos-
phorylation by Abl or Arg in vitro and in vivo.
PDGF stimulation causes cortactin to translocate
from a perinuclear region to colocalize with dynamin in
F-actin-rich circular dorsal waves [9] (Figure 3A). These
dorsal waves reorganize the actin structure and disas-
semble F-actin stress fibers to allow for subsequent
lamellipodial protrusion [9]. Abl and Arg are required
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448Figure 3. Abl/Arg-Mediated Phosphorylation of Cortactin Stimulates Dorsal-Wave Formation
(A) Treatment with 5 ng/ml PDGF for 10 min induces bright F-actin-rich dorsal waves in WT but not abl–/–arg–/– or SYF cells. Cortactin-RFP
is shown in red, dynamin is shown in green, and F-actin is shown in blue. Scale bars represent 10 mm.
(B) Cortactin-RFP and cortactin-3F-RFP were expressed at levels 1- to 2-fold greater than endogenous cortactin by infection of cells with
retrovirus.
(C) Cortactin phosphorylation is required for stimulating dorsal-wave formation. Expression of cortactin-RFP (cort) in WT cells increased the per-
centage of cells containing dorsal waves after PDGF treatment. Cortactin-3F-RFP (3F) did not affect the percentage of cells forming dorsal
waves. Mean 6 SEM. Data from two or three experiments were averaged. ANOVA between data for all genotypic classes, p < 0.0001. Post-
hoc Fisher’s PLSD for WT + RFP versus WT + cort-RFP: *p = 0.0028.for dorsal-wave formation [27], but their biochemical
roles in this process are unclear. Dorsal waves were
not observed and cortactin remained localized around
the nucleus after PDGF stimulation of SYF and
abl–/–arg–/– cells or STI-571-treated WT cells (Figure 3A
and Figure S4A). Expression of cortactin-RFP at 1.5-
fold endogenous levels (Figure 3B) in WT cells led to
an increased proportion of cells that exhibit dorsal
waves (Figure 3C). When expressed at a similar level,the cortactin-3F-RFP mutant did not promote increased
dorsal-wave formation in WT cells. Likewise, cortactin-
RFP does not increase dorsal-wave frequency in
abl–/–arg–/– or SYF cells. These data indicate that the
ability of cortactin to stimulate dorsal-wave formation
requires phosphorylation of Y421, Y466, and Y482.
We generated cortactin knockdown cells to examine
the requirement for cortactin phosphorylation in dor-
sal-wave formation. Cortactin knockdown (KD) cells
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449Figure 4. Dorsal-Wave Formation Requires
Abl/Arg-Mediated Phosphorylation of Cor-
tactin
(A) Treatment with 5 ng/ml PDGF for 10 min
induces dorsal waves in pSuper control WT
cells but not cortactin knockdown (KD) cells.
Dynamin is shown in green, and F-actin is
shown in blue. Scale bars represent 10 mm.
(B) Rescue of dorsal-wave formation. Dorsal
waves are observed with high frequency in
cortactin KD cells re-expressing RNAi-
resistant cortactin-RFP but not in cortactin
KD cells re-expressing RNAi-resistant cor-
tactin-3F-RFP (3F).
(C) Quantitation of cortactin levels. Cortactin
knockdown resulted in 94% reduction of cor-
tactin levels in cortactin knockdown (KD)
cells relative to pSuper control cells. The
levels of transfected cortactin-RFP and cor-
tactin-3F-RFP relative to endogenous levels
are indicated. The band at the same molecu-
lar weight as endogenous cortactin in lanes
3 and 4 represents re-expressed cortactin in
which the RFP tag was cleaved.
(D) Quantitation of dorsal-wave formation.
Re-expression of cortactin-RFP restores
PDGF-dependent dorsal-wave formation to
cortactin KD cells, whereas re-expression of
cortactin-3F-RFP does not. Mean 6 SEM.
Data from two experiments were averaged.
ANOVA between data for all genotypic clas-
ses, p = 0.0003. Post-hoc Fisher’s PLSD for
control versus knockdown, knockdown +
cort, and knock-down + cort-3F: *p < 0.005.that express cortactin at only approximately 6% of nor-
mal endogenous levels exhibit 56% fewer dorsal waves
after PDGF treatment (Figures 4A, 4C, and 4D). Re-
expression of RNAi-resistant cortactin-RFP in cortactin
KD cells rescues dorsal-wave formation (Figures 4B–
4D). However, RNAi-resistant cortactin-3F-RFP does
not rescue the deficit in dorsal-wave formation (Figures
4B–4D). Thus, phosphorylation of cortactin is necessary
for efficient dorsal-wave formation. Importantly, we did
not observe dorsal waves in the cortactin KD cells re-
expressing cortactin-3F-RFP over a 40 min period
(Figure S5), indicating that cortactin-3F-RFP does not
promote dorsal-wave formation with delayed kinetics.
Dorsal waves are enriched in cytoskeletal regulators
(e.g., Arp2/3 complex, N-WASp, WAVE1, and gelsolin)and adhesion complex proteins (paxillin and vinculin)
that may interact with cortactin in a phosphorylation-
dependent manner [9]. Our studies identify cortactin
as an Abl/Arg substrate and demonstrate that Abl/Arg-
mediated cortactin phosphorylation is required for dor-
sal-wave formation after PDGF treatment. Loss of an-
other Abl-family-kinase substrate, p190RhoGAP, does
not affect dorsal-wave formation (Figure S6). Thus, cor-
tactin represents a critical target of Abl-family kinases in
PDGF-induced dorsal-wave formation.
We used human protein microarrays to identify sub-
strates of the Abl and Arg kinases. Because kinases
are dysregulated in cancer and other human diseases,
this approach has the potential to identify critical down-
stream effectors of these disease processes. For
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450example, cells transformed with the constitutively active
Bcr-Abl kinase are hypermotile [32] and have reduced
chemotactic responses [21]. Our findings raise the in-
triguing possibility that these phenotypes result from
the altered function of cortactin or its hematopoietic-
specific ortholog HS1 [33] in these cells. Future studies
will establish how Abl/Arg-dependent regulation of
cortactin regulates cytoskeletal rearrangements and
cell migration during development and whether these
pathways become compromised in v-Abl or Bcr-Abl-
positive leukemias.
Supplemental Data
Supplemental Data include Experimental Procedures, six figures,
and one table and are available with this article online at http://
www.current-biology.com/cgi/content/full/17/5/445/DC1/.
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